http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101684574-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2014-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101684574-B1 |
| titleOfInvention | Pharmaceutical compositions and health functional foods comprising Cibotium barometz J. Smith extracts for preventing or treating anticancer agent-induced of hematopoietic toxicity |
| abstract | The present invention relates to a cibotium- baromet The present invention relates to a pharmaceutical composition for prevention and treatment of hematopoietic toxicity, which comprises an extract of Aspergillus oryzae Smith (J. Smith) extract as an active ingredient. Specifically, the extract of the present invention is effective for attenuating the efficacy of various anticancer drugs having different mechanisms, Since the bone marrow toxicity and the hematopoietic toxicity induced by the anticancer agent are effectively mitigated without accelerating the anticancer agent, the extract can be effectively used as an active ingredient of a pharmaceutical composition for the prevention and treatment of anticancer drug induced hematopoietic toxicity. |
| priorityDate | 2014-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 124.